2 ms·

Thanks a bunch for your response. Regarding cryptographic methods, I was indeed clutching at straws. It seems to me that current methods can convey that there

by srean 5y ago

Thanks a bunch for your response. Regarding cryptographic methods, I was indeed clutching at straws. It seems to me that current methods can convey that there are 'no obvious indicators of fraud', it would be nice if pharma had recourse to methods by which they could 'prove' that fraud couldn't have happened. I suppose it would be quite impossible to design such a protocol, 'best effort' is probably all one can do. I think mandatory pre-registration itself fixes many of the potential problems. On a different note: compilers and medical trials … I don't see those going together a lot.

gumby 5y ago
> On a different note: compilers and medical trials … I don't see those going together a lot. Or power generation or... I have enjoyed working in different domains requiring completely different technical skills. I have learned a lot. It's one thing to learn chemistry and lab techniques and protocol. It's another to present before the FDA who doesn't have any interest in what my previous career might have been.
- srean 5y ago
  Some folks, perhaps many folks like 'more wood behind fewer arrows' culture. I lean the other way, so I take interest in stories where people have moved from things to other things. For understandable reasons CS seems to have a lot of them. The Google reference is a little ironic, because at one point in time, say around 2004, it was a place where anything that's intellectually challenging and gratifying was fair game. I would assume Bell Labs would have been something like that.
  - gumby 5y ago
    > I would assume Bell Labs would have been something like that. Talking to people who worked there it seems it was much less so than it would appear. PARC was more like that.